Geusens P, et al. - Researchers compared the impact of teriparatide vs risedronate therapy on the risk of fractures in postmenopausal women presenting with severe osteoporosis. Compared with risedronate, the anti-fracture efficacy of teriparatide was consistent in a wide range of individuals including treatment-naïve and previously treated patients among the study group.